[1] Bai R, Ying X, Shen J, et al. The visceral and liver fat are significantly associated with the prevalence of hyperuricemia among middle age and elderly people: A cross-sectional study in Chongqing, China. Front Nutr, 2022,9:961792. [2] Guo W, Zhao X, Cheng D, et al. Muscle fat content is associated with nonalcoholic fatty liver disease and liver fibrosis in Chinese adults. Nutr Health Aging,2023,27(11):960-965. [3] Roderburg C, Kostev K, Mertens A, et al. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of extrahepatic cancer. Gut,2023,72(12):2383-2384. [4] Xu L, Duanmu Y, Blake GM, et al. Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference. Eur Radiol,2018,28(5):2003-2012. [5] Starekova J, Hernando D, Pickhardt PJ, et al. Quantification of liver fat content with CT and MRI: State of the art. Radiology,2021,301(2):250-262. [6] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南(2010年修订版). 中华肝脏病杂志,2010,18:(03):163-166. [7] 中华医学会肝病学分会.代谢相关(非酒精性)脂肪性肝病防治指南(2024年版).实用肝脏病杂志,2024,27(4): 494-510. [8] 中国研究型医院学会肝病专业委员会,中国医师协会脂肪性肝病专家委员会,中华医学会肝病学分会脂肪肝与酒精性肝病学组,等. 中国脂肪性肝病诊疗规范化的专家建议(2019年修订版). 中华肝脏病杂志,2019,27:(10):748-753. [9] Naga C, Zobair Y, Lavine Joel E, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology,2018,67: 328-357. [10] Cheng X, Blake GM, Brown JK, et al. The measurement of liver fat from single-energy quantitative computed tomography scans. Quant Imaging Med Surg,2017,7(3):281-291. [11] 农晓黎, 陈菲, 詹浩洪, 等. 体检人群非酒精性脂肪性肝病发病率及其相关危险因素分析. 实用肝脏病杂志,2024,27(3): 353-356. [12] Guo W, Zhao X, Miao M, et al. Association between skeletal muscle mass and severity of steatosis and fibrosis in non-alcoholic fatty liver disease. Front Nutr,2022,9:883015. [13] DiStefano JK, Gerhard GS. Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index. Curr Opin Gastroenterol,2023,39(3):156-162. [14] Fan R, Wang J,Du J, Association between body mass index and fatty liver risk: A dose-response analysis. Sci Rep,2018,8:15273-15280. [15] Hydes T, Brown E, Hamid A, et al. Current and emerging biomarkers and imaging modalities for nonalcoholic fatty liver disease: Clinical and research applications. Clin Ther,2021,43(9):1505-1522. [16] Harald K,Pickhardt Perry J,Kliewer Mark A, et al. Accuracy of liver fat quantification with Advanced CT, MRI, and ultrasound techniques: Prospective comparison with MR Spectroscopy. AJR,2017,208:92-100. [17] 过哲,付晓霞,唐雪,等. 中国健康定量CT大数据项目研究方案. 中华健康管理学杂志,2018,12:(6):510-513. [18] Kan H, Kimura Y,Hyogo H,et al. Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease. HepatolRes,2014,44(14):420-427. [19] Mccullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clinics in liver disease,2004,8(3):521-533. [20] Ruben H, Mariana L, Susanne B, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology, 2011, 54: 1082-1090. [21] Wu Y, Guo Z, Fu X, et al. The study protocol for the China Health Big Data (China Biobank) project. Quant Imaging Med Surg,2019,9(6):1095-1102. [22] Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology,2017,66(5):1486-1501. [23] Wang XM, Zhang XJ, Ma L. Diagnostic performance of magnetic resonance technology in detecting steatosis or fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Medicine (Baltimore),2018 May,97(21):e10605. |